相关实验视频
Updated: Jun 11, 2025

06:07
Measuring Mitochondrial Function of Naïve and Effector CD8 T Cells
Published on: March 28, 2025
208
癌症能量代谢和免疫微环境中的糖解相关 lncRNA:一个神奇的钥匙
Xi Zhang1, Yunchao Zhang1, Qiong Liu1
1School of Medical and Life Sciences, Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan, China.
Frontiers in immunology
|September 30, 2024
概括
长链非编码RNAs (LncRNAs) 调节瘤糖解,提供新的癌症治疗点. 向LncRNAs可以抑制瘤生长,转移和耐药性,从而推进精确医学.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 生物化学 生物化学
背景情况:
- 瘤细胞依赖糖解来获得能量和生长.
- 长链非编码RNA (LncRNAs) 在瘤糖解中起着关键的调节作用.
- LncRNAs在癌症治疗中提供了新的治疗机会.
研究的目的:
- 审查瘤糖解中的LncRNA机制.
- 探索癌症能量代谢中LncRNA介导的变化.
- 讨论基于LncRNA的治疗策略及其潜力.
主要方法:
- 关于LncRNAs和瘤糖解的当前文献的综述.
- 对与关键酶,转录因子和miRNAs的LncRNA相互作用的分析.
- 检查LncRNA在乳酸生产和运输中的作用.
主要成果:
- LncRNAs调解关键的糖解酶的表达.
- LncRNAs影响乳酸的产生,运输和与其他分子的相互作用.
- 向LncRNAs可以抑制瘤生长,转移,并调节免疫/药物耐药性.
结论:
- LncRNAs是瘤糖解的关键调节者,揭示了癌症新陈代谢的异常机制.
- LncRNAs作为个性化癌症治疗和预后的潜在分子标记物.
- 对LncRNA糖解调节的进一步研究将推动精准医学的进步.
相关概念视频
lncRNA - Long Non-coding RNAs
8.5K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.5K
Adaptive Mechanisms in Cancer Cells
5.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
The Tumor Microenvironment
6.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K
Cancer-Critical Genes II: Tumor Suppressor Genes
7.3K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.3K
Tumor Immunotherapy
489
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
489

